CCPE
CCPE estimates cell cycle pseudotime and identifies cell cycle phases from single-cell RNA-seq (scRNA-seq) data to characterize timing and progression of cellular events.
Key Features:
- Pseudotime Estimation: Maps continuous progression of cells through the cell cycle using pseudotime analysis on scRNA-seq data.
- Discriminative Helix Model: Represents the circular nature of the cell cycle with a discriminative helix model to estimate cyclic pseudotime.
- Robustness to Dropout Events: Maintains performance in the presence of scRNA-seq dropout events to support phase identification from sparse data.
- Identification of Cell Cycle Marker Genes: Identifies marker genes associated with distinct cell cycle stages for annotation of cell states.
- Performance Evaluation: Evaluated on simulated and real scRNA-seq datasets to assess accuracy and competitiveness with existing methods.
Scientific Applications:
- Cell cycle effect correction: Enables removal of cell cycle–associated variation from scRNA-seq data to reveal other biological signals.
- Temporal dynamics analysis: Characterizes timing of gene expression in developmental biology, cancer progression, and stem cell differentiation studies.
- Cell state annotation: Supports assignment of cell cycle phases and annotation of cell states via detected marker genes.
Methodology:
Discriminative helix model for circular representation of the cell cycle; pseudotime estimation of cellular progression; robustness to scRNA-seq dropout events; evaluation on simulated and real scRNA-seq datasets.
Topics
Details
- License:
- Not licensed
- Cost:
- Free of charge
- Tool Type:
- command-line tool
- Operating Systems:
- Mac, Linux, Windows
- Programming Languages:
- MATLAB, R, Python
- Added:
- 6/2/2022
- Last Updated:
- 6/2/2022
Operations
Publications
Liu J, Yang M, Zhao W, Zhou X. CCPE: cell cycle pseudotime estimation for single cell RNA-seq data. Nucleic Acids Research. 2021;50(2):704-716. doi:10.1093/nar/gkab1236. PMID:34931240. PMCID:PMC8789092.
DOI: 10.1093/NAR/GKAB1236
PMID: 34931240
PMCID: PMC8789092
Funding: - National Institutes of Health: R01CA241930, R01GM123037, U01AR069395-01A1